Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 10, 2001

View Archived Issues

MorphoSys Enters EUR22M Deal With Centocor Around HuCAL

SHIP2 Gene Makes Waves As Potential Type II Diabetes Target

European Parliament Report Calls For Separation Of Biotech Areas

Xantos Formed Around Platform To Perform Functional Genomics

GenOdyssee Applies For Patents Covering Genetic Variants Method

Other News To Note

MediGene's Genital Warts Drug Enters Phase III Clinical Trials

Combio Spun Off From Carlsberg To Develop Chemistry Platform

Oxford BioMedica Moving To LSE Following TroVax Trial Approval

Eurofins Beefing Up Detection Business Through Acquisitions

Phytopharm Sees Encouraging Results In Phase I P54 Study

PhotoCure Reports Skin Cancer Cures In Phase III PDT Trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.